Gastro-esophageal reflux disease with esophagitis, without bleeding
Methodology & AI Transparency ⓘ
Gastro-esophageal reflux disease with esophagitis, without bleeding Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Gastro-esophageal reflux disease with esophagitis, without bleeding is an ICD-10-CM indexed diagnosis (K21.00) within Acid Reflux, GERD & Upper GI Health.
- 2 Real-world patient consensus: Mapped to Acid Reflux, GERD & Upper GI Health under ICD-10-CM K21.00 for Gastro-esophageal reflux disease with esophagitis, without bleeding clinical workups.
- 3 Typical cash cost range: Workup highlights for Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00): step-down acid suppression in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: review).
- 4 Top reported side effects / signs: Objective lab/clinical target for Gastro-esophageal reflux disease with esophagitis, without bleeding: H. pylori Stool in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Antigen or Urea) (Negative (K21.00)) and Hemoglobin & Serum in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Ferritin).
Ask our AI Specialists anything about Gastro-esophageal reflux disease with esophagitis, without bleeding
What Is Gastro-esophageal reflux disease with esophagitis, without bleeding?
Gastro-esophageal reflux disease with esophagitis, without bleeding is an ICD-10-CM indexed diagnosis (K21.00) within Acid Reflux, GERD & Upper GI Health. Clinical evaluation centers on step-down acid suppression in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: review) alongside serial H. pylori Stool in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Antigen or Urea) tracking (Negative (K21.00)) to guide individualized care.
Pathophysiology, Underlying Causes & Clinical Presentation
At the cellular and tissue level in gerd & stomach, Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00) involves transient lower esophageal in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: sphincter relaxation). progression correlates with shifts in H. pylori Stool in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Antigen or Urea) (Negative (K21.00)).
Common Symptoms & Clinical Signs
- • Presentation of Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00): chronic throat clearing, in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: hoarseness, nocturnal cough,)
- • Secondary Gastro-esophageal reflux disease with esophagitis, without bleeding clinical sign: nausea, belching, or in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: discomfort relieved or)
- • Symptom flares in Gastro-esophageal reflux disease with esophagitis, without bleeding correlating with H. pylori Stool in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Antigen or Urea) deviation outside Negative (K21.00)
- • Functional gerd & stomach impact requiring step-down acid suppression in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: review) evaluation (K21.00)
Gastro-esophageal reflux disease with esophagitis, without bleeding Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | K21.00 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Acid Reflux, GERD & Upper GI Health | NLM Clinical Tables |
| Diagnostic / Lab Marker: H. pylori Stool in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Antigen or Urea) | Negative (K21.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hemoglobin & Serum in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: Ferritin) | Ferritin > 50 ng/mL (no occult loss) (K21.00) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Serum Vitamin B12 in Gastro-esophageal reflux disease with esophagitis, without bleeding (K21.00: & Magnesium (chronic) | B12 > 450 pg/mL; Mg >= 2.0 mg/dL (K21.00) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Gastro-esophageal reflux disease with esophagitis, without bleeding
Treatment selection for Gastro-esophageal reflux disease with esophagitis, without bleeding depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Gastro-esophageal reflux disease with esophagitis, without bleeding)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of Tofacitinib in Ulcerative Colitis Based on Prior Tumor: What a 1,139-Participant Study Found Tofacitinib was efficacious in patients with UC regardless of prior TNFi failure status. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association • 2022-03-15 • Phase III Randomized Trial | N = 1,139 | 96/100 | PMID 33684552 ↗ |
| New Insights on Relationship between obstructive sleep apnea hypopnea syndrome and chronic acid: What a 2,699-Participant Study Found The meta-analysis showed that there was a significant correlation between obstructive sleep apnea hypopnea syndrome and chronic acid reflux. Sleep & breathing = Schlaf & Atmung • 2019-06-15 • Meta-Analysis | N = 2,699 | 94/100 | PMID 29987514 ↗ |
| New Insights on Association between obstructive sleep apnea and chronic acid: What a 2,950-Participant Study Found There exists an association between OSA and chronic acid reflux that is independent of the modalities used for screening or diagnosing both disorders. Journal of gastroenterology and hepatology • 2023-08-15 • Meta-Analysis | N = 2,950 | 94/100 | PMID 37300443 ↗ |
| New Insights on Olanzapine With or Without Fosaprepitant for Preventing Chemotherapy Induced: What a 690-Participant Study Found This trial did not provide sufficient evidence to support that deletion of the NK-1 receptor antagonist was as good as keeping it, as a part of a 4-drug antiemetic regimen for highly emetogenic chemotherapy. The oncologist • 2023-08-03 • Phase III Randomized Trial | N = 690 | 93/100 | PMID 37284847 ↗ |
| New Insights on Benefits and safety of GutGard® in Managing Gastroesophageal Reflux-Related: What a 296-Participant Study Found The GutGard® group showed better and earlier resolution (within 2 weeks) of symptoms of GER as against the placebo group, especially heartburn and regurgitation. Complementary medicine research • 2025-01-15 • Phase III Randomized Trial | N = 296 | 93/100 | PMID 39929150 ↗ |
Gastro-esophageal reflux disease with esophagitis, without bleeding Patient Community & “People Like Me” Threads
Filter Gastro-esophageal reflux disease with esophagitis, without bleeding community threads and patient logs by age, biological sex, dosage, and treatment duration.